The Enterprise Value as of November 2024 (TTM) for Veracyte, Inc. (VCYT) is 2.47B

According to Veracyte, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.47B. This represents a change of 62.50% compared to the average of 1.52B of the last 4 quarters.

Veracyte, Inc. (VCYT) Historical Enterprise Value (quarterly & annually)

How has VCYT Enterprise Value performed in the past?

The mean historical Enterprise Value of Veracyte, Inc. over the last ten years is 1.06B. The current 2.47B Enterprise Value has changed 23.32% with respect to the historical average. Over the past ten years (40 quarters), VCYT's Enterprise Value was at its highest in in the March 2021 quarter at 3.10B. The Enterprise Value was at its lowest in in the September 2015 quarter at 88.52M.

Veracyte, Inc. (VCYT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Veracyte, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Veracyte, Inc. (VCYT) Average Enterprise Value

How has VCYT Enterprise Value performed in the past?

The current Enterprise Value of Veracyte, Inc. (VCYT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Veracyte, Inc. (VCYT) Enterprise Value vs. Peers

How is VCYT’s Enterprise Value compared to its peers?

Veracyte, Inc.’s Enterprise Value is less than Crinetics Pharmaceuticals, Inc. (4.87B), greater than Viridian Therapeutics, Inc. (1.66B), less than Cytokinetics, Incorporated (6.66B), greater than Structure Therapeutics Inc. (1.90B), greater than Icosavax, Inc. (713.87M), greater than Kura Oncology, Inc. (1.34B), greater than Protagonist Therapeutics, Inc. (2.41B), less than Merus N.V. (3.08B), greater than Replimune Group, Inc. (745.52M), less than Cerevel Therapeutics Holdings, Inc. (8.24B), greater than Enanta Pharmaceuticals, Inc. (425.20M), greater than Syndax Pharmaceuticals, Inc. (1.51B), greater than Ventyx Biosciences, Inc. (122.28M), greater than uniQure N.V. (517.32M), greater than Rocket Pharmaceuticals, Inc. (1.52B), less than Rhythm Pharmaceuticals, Inc. (3.33B), greater than Solid Biosciences Inc. (147.89M), greater than MeiraGTx Holdings plc (448.89M), greater than IDEAYA Biosciences, Inc. (2.15B), greater than AnaptysBio, Inc. (909.29M), greater than Keros Therapeutics, Inc. (1.86B), greater than Homology Medicines, Inc. (-103303255.00),

Build a custom stock screener for Veracyte, Inc. (VCYT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Veracyte, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Veracyte, Inc. (VCYT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Veracyte, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.